Facilitating strategic connections
that drive life science dealmaking.
6 Global events
11,644 Executive-level attendees attracted
48,347 One-to-one partnering meetings held
6,673 Attending companies
60 Countries represented
12,193 Licensing opportunities on offer
We consistently provide valuable in-depth insight and analysis on the most recent trends in life science and partnering. Don't miss the latest releases!
Get the facts before you make your next deal. This newly published report reveals an analysis and review of the last 18 months of biopharma dealmaking. Alongside venture capital and public market investment, biopharmaceutical company alliances remain key sources of capital for advancing drug discovery and development efforts across the industry. Download this FREE report now.
On May 22, Seattle biotech writer Luke Timmerman reached the summit of Mt. Everest while raising $339,000 for cancer research at Fred Hutch. He is now back and sharing what he learned during his two-month journey and what it taught him about leadership and teamwork.
It takes a special combination of passion, strategy, partners, and talent for a biotech startup to prosper. So, what do you do to get there? Follow this webinar series for valuable insights and advice from leading industry experts and entrepreneurs making their biotech dreams come alive.
partneringONE is even more powerful than before. New features and functionality will increase your productivity and improve your partnering experience. Look out for a mobile-responsive platform, time-saving message templates and enhanced search capabilities and collaboration tools.
FIND OUT MORE
Our network of more than 40,000 high-value dealmakers, companies and assets from around the world are looking for "best-fit" partners.
Find out more© 2008-2018 EBD GmbH/EBD Group
EBD Group is part of
is an Informa business